Tahapary Dicky Levenus, Oswari Selfy, Kusumawati Maya, Lubis Dian Anindita, Minuljo Tania Tedjo, Yunus Reyhan Eddy, Kodrat Henry, Permana Affan Priyambodo, Rosana Martha, Purwoto Johanes, Puspitasari Leny, Novida Hermina, Sanusi Himawan, Nusanti Syntia, Tarigan Tri Juli Edi, Soewondo Pradana, Suastika Ketut
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Department of Neuro Surgery/ Pusat Otak Nasional Hospital, Jakarta, Indonesia.
J ASEAN Fed Endocr Soc. 2025 May;40(1):8-13. doi: 10.15605/jafes.040.01.03. Epub 2025 Apr 29.
Pituitary adenomas account for 10 to 15% of all intracranial masses and are the most common type of pituitary disorder. Their clinical manifestations can vary based on the tumor size and whether they secrete excess hormones. Occasionally, they are incidentally diagnosed following an imaging procedure for other indications (pituitary incidentaloma). The Pituitary Working Group of the Indonesian Society of Endocrinology has identified pituitary adenoma as a priority and has called for the development of updated evidence-based practice guidelines. These guidelines aim to provide evidence-based, comprehensive and multidisciplinary recommendations for diagnosing pituitary adenomas in Indonesia and to navigate the limitations of diagnosing pituitary adenomas in Indonesia.
垂体腺瘤占所有颅内肿块的10%至15%,是最常见的垂体疾病类型。其临床表现会因肿瘤大小以及是否分泌过多激素而有所不同。偶尔,它们会在因其他指征进行影像学检查时被偶然诊断出来(垂体偶发瘤)。印度尼西亚内分泌学会垂体工作组已将垂体腺瘤确定为优先事项,并呼吁制定更新的循证实践指南。这些指南旨在为印度尼西亚垂体腺瘤的诊断提供循证、全面且多学科的建议,并应对印度尼西亚垂体腺瘤诊断中的局限性。